making accurate, valuable information accessible
Well, frankly, not much.
Medical education (med ed) agencies are virtually the same as medical communications agencies, and at Rx Communications we call ourselves by either term. Some med ed agencies focus on delivering marketing & training materials that help pharmaceutical and medical devices companies educate patients, subscribers and payers not only about their product but also about disease awareness. Other medical communications agencies may concentrate on developing the scientific platform for key opinion leaders (KOLs), which would include scientific and clinical journal publications as well as congress materials. Yet others may focus on clinical trial documents and regulatory materials. With our range of writer expertise and superb project management, we can manage it all. We deliver quality clinical and pre-clinical study protocols, reports and investigator materials, alongside medical communications and medical education in whatever format our clients want.
Our only criterion is that the project in question has a valid scientific foundation so that whatever we do adds to an evidence base that supports and encourages good healthcare information and decision-making.
EBM or evidence-based medicine is vital for improving healthcare. And so much of it now incorporates the use of big data and outcomes research. The sheer volume of data can make the job of communication a tricky one – data selection is vital but must not bias the evidence. This is where publications planning and communications strategy comes in.
Initially, the focus should be on understanding how, when and why healthcare decisions are made – and of course, who makes them. By healthcare decisions we mean decisions right from the top, e.g. government policy, regulatory authorities, formulary committees etc. right down to the selection of a particular wound covering made by a nurse, a prescription by a subscriber, or an OTC (over the counter) healthcare product decision made by a patient/consumer.
A medical communications agency worth its salt should help find the answers to these questions, take the evidence available, perform the necessary competitor and benchmarking analyses and be able to come up with a publications plan and/or communications strategy that fulfils these criteria for the decisionmakers that are most important to the client.
Of course, to collect ALL the evidence necessary to fulfil every audience/decisionmaker in every country is an impossible task. And hugely expensive. So the next questions become: Who are the most important target audiences, and when, how and what do they need to know/understand to make healthcare decisions?
Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you to know what they think of us anyway!
RetinAI Medical AG has announced the launch of their Discovery CORE™ software suite. The software uses artificial intelligence (AI) models to help speed retinal fluid and layer segmentation […]
The UK agency Innovate UK established the idea of self-driven healthcare (SDH), a broad term covering strategies to help engage patients in their own healthcare. In a newly published paper in the […]
The first real-world evidence (RWE) studies have begun in the DARWIN EU initiative of the European Medicines Agency (EMA). The project is a collaboration between the European Commission and the […]
WOW! What a buzz around Real Word Evidence (RWE)! I don’t think I have ever heard so much enthusiasm and expression of need for RWE and collaboration between European (EU)…
What to watch out for at ISPOR Europe 2022 This year the theme for the ISPOR European conference to be held in Vienna, 6-9 November is Collaborating Across Boarders:…
The field of psychoneuroimmunology has blossomed over the last three decades, as researchers and physicians alike have sought to elucidate the multifactorial nature of a variety of diseases. The specialty…
July is Sarcoma Awareness Month, providing people with the opportunity to learn more about this rare form of cancer that claims the lives of more than 5,000 Americans annually. Between…
Major pharmaceutical companies strive to take full advantage of digital transformation, as evidenced by recent mergers and acquisitions (M&A) and equity investments1. The pandemic unrolled many innovative solutions which enable…
Believe it or not, it is generally unethical to deliberately infect someone with a disease (not the best way to start a medical communications piece, but bear with me). However,…
Get our Health Outcomes Communicator direct to your inbox – sign-up now!
Please note: we will not pass your details on to any third-parties. View our Privacy Policy here.
